Goods
Kimberly-Clark agrees to buy Tylenol owner Kenvue in $48.7 billion deal, creating consumer staples giant
Published Mon, Nov 3 20257:49 AM ESTUpdated 29 Min Ago
Amelia Lucas @Thxamelian
Annika Kim Constantino @annikakimc
Sara Salinas @in/saracsalinas @saracsalinas
WATCH LIVE
Key Points
- Kimberly-Clark announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion.
- The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would generate estimated 2025 annual net revenues of roughly $32 billion.
- Kenvue spun out of Johnson & Johnson in May 2023. Since then, shares have fallen almost 35% from their initial public offering price.
In this article
KMB-14.50 (-12.12%)
Huggies, manufactured by Kimberly-Clark and Band-Aid, manufactured by Kenvue.
Getty Images
Kimberly-Clark
announced Monday it’s struck an agreement to buy Kenvue in a deal valued at $48.7 billion that would create a consumer staples giant.
The deal is a combination of cash and stock. Shares of Kenvue surged 15% in early trading Monday, while shares of Kimberly-Clark fell 12%.
The combined company would bring together brands like Huggies and Kleenex with the likes of Band-Aid and Tylenol. It would include 10 billion-dollar brands, the companies said in a news release. The acquisition would be one of the largest on Wall Street this year.
The transaction is expected to close in the second half of 2026.
Kimberly-Clark Chairman and CEO Mike Hsu said in a statement that the companies share a “commitment to developing science and technology to provide extraordinary care.”
“Over the last several years, Kimberly-Clark has undertaken a significant transformation to pivot our portfolio to higher-growth, higher-margin businesses while rewiring our organization to work smarter and faster,” Hsu said. “We have built the foundation and this transaction is a powerful next step in our journey.”
Kenvue, a portfolio of consumer health brands, spun out of Johnson & Johnson
in May 2023, marking the biggest shake-up in J&J’s nearly 140-year history. Since then, Kenvue shares have fallen almost 35% from their initial public offering price. As of Friday’s close, Kenvue traded at about $14 per share for a market cap of roughly $27 billion.
J&J has sold all of its remaining stake in the consumer goods giant.
watch now
VIDEO07:35
Kimberly-Clark agrees to buy Tylenol owner Kenvue, creating consumer staples giant
The deal comes just weeks after President Donald Trump made unfounded claims linking the use of acetaminophen — the active ingredient in Tylenol — during pregnancy to an increased risk of autism, sending Kenvue’s stock sharply lower. The company has staunchly pushed back against his administration’s accusation, and many medical experts say Tylenol is often the safest and only option for pain and fever relief in pregnant women.
Acetaminophen is used by upward of 100 million Americans annually.
Kenvue Chair Larry Merlo said in a statement that following a comprehensive strategic review, the board is “confident this combination represents the best path forward for our shareholders and all other stakeholders.”
Three Kenvue board members will join the Kimberly-Clark board upon the deal’s closing. Hsu will continue to serve as CEO.
The combined company would generate estimated 2025 annual net revenues of roughly $32 billion and adjusted EBITDA of approximately $7 billion, according to the release.
Kimberly-Clark and Kenvue expect about $1.9 billion in cost synergies from the transaction to be realized in the first three years following the deal’s close.
The acquisition comes as Kimberly-Clark and the broader consumer packaged goods industry try to address shifting demand and shopping behavior, often through dealmaking and divestitures.
Tariffs imposed by Trump’s administration have challenged the industry and its profits as key commodities like pulp, which is used to make tissues and diapers, grow more expensive.
At the beginning of 2025, Kimberly-Clark stopped making private-label diapers for Costco
to focus on more premium brands that command higher margins.
In June, the company sold a majority stake in its international tissue business to Brazilian pulp maker Suzano. The resulting joint venture is intended to shield Kimberly-Clark from volatile input costs and help stabilize its margins.
Once the deal closes, Kimberly-Clark will own health-care brands like Sudafed and Pepcid, once again pitting the company against rival Procter & Gamble
, which has a health-care division that includes Pepto Bismol and Vicks.
But even with Kimberly-Clark’s blockbuster acquisition, P&G still dwarfs its rival in both enterprise value and annual revenue. P&G has a market cap of about $350 billion.
Similar to Kenvue, other spinoffs have also recently proven to be popular acquisition targets. Last year, candy maker Mars announced plans to buy Kellanova
, a snacking-centric spinoff of Kellogg, while Ferrero bought W.K. Kellogg, the cereal standalone, this year.
In this article
KMB-14.50 (-12.12%)
Trending Now
-
Michigan lawyer says a Halloween terror plot that FBI Director Kash Patel described never existed
-
OpenAI signs $38 billion compute deal with Amazon, partnering with cloud leader for first time
-
I’ve studied over 200 kids—these 7 ‘magic phrases’ can calm any tantrum instantly
-
People without kids should make this money move before it’s too late, estate planning expert says
Claim 150 Free Spins Jackpotcity :
Sponsored
Claim Your 150 Free SpinsJackpotcity :
Sponsored
Play Classic Slots Like Gold Blitz on ToonieBetEnjoy easy access and exciting betting opportunitiesToonieBet :
Sponsored
MORE IN CONSUMER GOODS
Cramer says Amazon CEO Andy Jassy just sent a very expensive message to the bearsPaulina Likos
FROM THE WEB
Turn Your 200 Free Spins Into Winnings! [Sign Up]Join Betty.com for the easiest online casino experience. Safe & secure casino experience. One of the fastest growing Canadian casinos. 100% Made in Canada!Betty Canada :
Sponsored
Instant Withdrawals and 200 Free Spins [Sign Up]Join Betty.com for the easiest online casino experience. Safe & secure casino experience. One of the fastest growing Canadian casinos. 100% Made in Canada!Betty Canada :
Sponsored
New Westminster: 7 out of 10 Canadians are considering this to boost their incomeCanadian Retirement Planning :
Sponsored
MORE FROM CNBC
Chinese e-commerce giants now dominate Southeast Asia’s online shopping sceneEvelyn Cheng
- News TipsGot a confidential news tip? We want to hear from you.
Get In Touch - CNBC NewslettersSign up for free newsletters and get more CNBC delivered to your inbox
Sign Up NowGet this delivered to your inbox, and more info about our products and services.
- Advertise With Us Please Contact Us
© 2025 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Market Data Terms of Use and DisclaimersData also provided by  |
